|
Product Name: | HA-155 | Synonyms: | Boronic acid, B-[4-[[4-[[3-[(4-fluorophenyl)methyl]-2,4-dioxo-5-thiazolidinylidene]methyl]phenoxy]methyl]phenyl]-;HA-155 4-((4-((3-(4-Fluorobenzyl)-2,4-dioxo-1,3-thiazolan-5-yliden)-methyl)phenoxy)methyl)benzene boronic acid;Autotaxin Inhibitor IV;inhibit,Inhibitor,HA155,Phosphodiesterase (PDE),(E/Z)-HA155,HA 155,Pain,Cancer,Inflammation,Angiogenesis,Fibrotic diseases,Autotaxin;(E/Z)-HA155 | CAS: | 1229652-22-5 | MF: | C24H19BFNO5S | MW: | 463.29 | EINECS: | | Product Categories: | | Mol File: | 1229652-22-5.mol | ![HA-155 Structure](CAS/20181012/GIF/1229652-22-5.gif) |
| HA-155 Chemical Properties |
storage temp. | Store at -20°C | solubility | DMF:50.0(Max Conc. mg/mL);107.92(Max Conc. mM) DMSO:30.0(Max Conc. mg/mL);64.75(Max Conc. mM) | form | A crystalline solid | color | Off-white to light yellow |
| HA-155 Usage And Synthesis |
Uses | HA 155 inhibits autotaxin (ATX) - mediated lysophosphatidylcholine (LPC) hydrolysis. |
| HA-155 Preparation Products And Raw materials |
|